The assessment of progenitor cell survival and efficacy after transplantation is one of the major challenges in cardiovascular cell therapy. Translation of currently used imaging techniques to patients is not immediate. Possible options include iron oxide particle loading into cells to be tracked using magnetic resonance (MR) and by MR-based water diffusion anisotropy analysis. The aim of the present study was to assess, using these techniques, the localization and survival of human 'early' endothelial progenitor cells (EPCs) and their effects on vascular and skeletal muscle regeneration in a mouse model of hind limb ischaemia.
Aims
The assessment of progenitor cell survival and efficacy after transplantation is one of the major challenges in cardiovascular cell therapy. Translation of currently used imaging techniques to patients is not immediate. Possible options include iron oxide particle loading into cells to be tracked using magnetic resonance (MR) and by MR-based water diffusion anisotropy analysis. The aim of the present study was to assess, using these techniques, the localization and survival of human 'early' endothelial progenitor cells (EPCs) and their effects on vascular and skeletal muscle regeneration in a mouse model of hind limb ischaemia.
Methods and results
A paramagnetic iron oxide particle loading protocol of human peripheral blood-derived early EPCs was devised. The iron þ EPCs maintained their phenotype and in vitro functional activity. In addition, the presence of iron þ cells was observed by MR until 7 days after injection into a pharmacologically immunosuppressed mouse model of hind limb ischaemia. Immunohistochemistry with human major histocompatibility complex antibodies revealed the absence of human cells at 7 days post-ischaemia. EPC death was confirmed by staining of iron þ cells with an antimouse CD68 antibody and by qPCR performed on DNA extracted from injected ischaemic limbs, at different times following injection. Surprisingly, early EPC injection enhanced arteriogenesis but caused a significant increase in ischaemic tissue inflammation and a retarded muscle regeneration, as evidenced by water diffusion anisotropy analysis and histology.
Conclusion
In line with recent reports, our results show that the use of iron-based contrast agents does not allow detection of long-term EPC engraftment into ischaemic tissues. They further show that early EPCs exert a potent arteriogenic effect on ischaemic tissues that is not dependent on their prolonged survival. Unexpectedly, injection of these cells elicited a long-term inflammatory response that reflected a delayed muscle healing process.
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Introduction
The success of cellular therapy in tissues affected by ischaemia depends on the ability to follow the engraftment of progenitor cells using techniques that may be translated into clinical practice. 1 Another important goal is represented by the need for devising live imaging techniques enabling correlation of the clinical outcome and the regeneration ability of progenitor cells. This is particularly important in the light of recent meta-analysis studies showing that the improvement in heart function observed in progenitor cell-treated patients compared with placebo-treated patients is still modest. 2 -6 An approach that has been proposed to detect injected stem cells in ischaemic tissues is magnetic resonance imaging (MRI) of cells loaded with super-paramagnetic iron oxide (SPIO) particles. In fact, the use of iron particles as contrast agent allows, at least theoretically, detection of engrafted stem cells with a minimal resolution of 10 5 cells using conventional MRI scanners; 7 in addition, the loading procedure with SPIO particles is relatively easily performed, does not require genetic engineering, and exploits reagents that are approved for use in humans. A major limitation of this technique is, however, the release of iron particles from dead cells and their uptake from resident cells that may lead to overestimation of stem cell survival at long times after transplantation. 1 Recent studies have shown that architectural organization of regenerating skeletal muscle or heart left ventricle during remodelling after ischaemic injury can be resolved by analysis of water diffusion anisotropy or diffusion tensor imaging (DTI). 8 -12 Different indices can be resolved by this multi-dimensional water diffusion acquisition protocol: T2 maps, showing the amount of 'unbounded' water, related to the presence of oedema; the fractional anisotropy (FA), which gives a simple numeric score for the 'form factor' of fibres (length/section); the apparent diffusion coefficient (ADC), an estimate of the diffusing compartment size; l 1 , l 2 , and l 3 diffusion tensor eigenvectors, which represent the three-dimensional (3D) directions and the forces associated with water diffusion in the muscle relative to fibre orientation and cross-sectional area. Thus far, DTI has not been applied to detect structural modification of the skeletal and cardiac muscle following progenitor cell injection.
In the present report, we first used SPIO loading to detect human 'early' endothelial progenitor cells (EPCs) 13 transplanted into mouse ischaemic limbs using MRI. In keeping with recent results obtained in animal models of myocardial infarction with mesenchymal stem cells (MSCs) and heart-derived stem cells, 14, 15 we found that lowered T2 signal areas, due to the presence of iron-loaded cells, did not correlate with survival of injected cells. By using histology and DTI analysis by MR, we found that EPC injection induced arteriogenesis in ischaemic muscles, but also caused a sustained inflammatory response associated with a delayed muscle regeneration.
Methods
In vivo procedures
The experimentation in the present study, involving the use of animals and human cells, conforms with the Guide for the Care and Use of 
Preparation and culture of human EPCs
Human peripheral blood from healthy volunteers was collected in EDTA solution. Peripheral blood mononuclear cells (PBMCs) were obtained by Ficoll Histopaque gradient centrifugation (Linfoprep; AxisShield, Oslo, Norway). PBMCs were recovered from gradients and washed using PBS with 2% FBS. EPCs culture was performed as described. 17 Further description of EPCs culturing is described in the Supplementary material online.
EPCs labelling
SPIO particles (Feridex, Guerbet, France) were transfected into human EPCs using polylysine (PLL). Iron was diluted at 25 mg/mL into complete M199 medium and then PLL (Sigma) was added to the solution at 375 ng/mL. The solution containing Feridex-SPIO particles and PLL was allowed to mix in a rotator for 1 h to allow the SPIO-PLL complex formation. EPCs were transfected on the 5th day of culture by incubation with M199 medium containing SPIO -PLL complex for 48 h.
In vitro MRI
After labelling, cells were washed three times with PBS to remove excess of SPIO -PLL complexes and trypsinized. Different numbers of control and SPIO-labelled cells were embedded into 100 mL of lowmelting agarose gel into PCR tubes. In vitro imaging of iron-labelled EPCs was performed into a vertical 4.7 T Bruker Avance II 200 system with 15 cm bore (Bruker, Germany). Further details about the in vitro MRI procedure are described in the supplementary online material.
Iron staining and EPC phenotype assessment
To detect intracellular iron particles, Pearl's staining was used. After fixation with 4% paraformaldehyde, EPCs were incubated for 20 min with 2% potassium ferrocyanide in 6% HCl, washed again, and counterstained with nuclear fast red (Sigma). Intracytoplasmic blue granules were detected using Axioskop 2 microscope (Zeiss, Germany). To assess endothelial phenotype of EPC colonies, control and SPIOlabelled EPCs at 7th day of plating were incubated for 4 h at 378C with DiI-Ac-LDL (Biomedical Technologies) diluted at 25 mg/mL concentration in culture medium as described previously. 16 Further details about staining procedures are described in the Supplementary material online.
Flow cytometry
Flow cytometry was performed using a FACSAria flow cytometer (Becton-Dickinson). Control and SPIO-labelled EPCs were analysed after 7 days in culture. Antibody description is provided in the Supplementary material online.
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In vivo MRI and DTI analysis
In vivo MRI analysis was performed using a vertical 4.7 T Bruker Advance II 200 system with 15 cm bore (Bruker). Animals were analysed at the 1st and the 7th day after surgery, before sacrifice. The imaging plane was localized using scout images in a transversal plane (see Supplementary material online, Figure S1 ). Full details about MRI and DTI in vivo are provided in the Supplementary material online.
Histology, arteriole length density determination, and immunohistochemistry
At days 7 and 21 after ischaemia, animals were sacrificed for histological analysis immediately after MRI analysis. They were anaesthetized and perfused with 4% formaldehyde. Ischaemic adductor and gastrocnemius muscles were collected and either paraffin-embedded for histological analysis or frozen to perform immunohistochemistry. To evaluate the angiogenic effect of EPCs on ischaemic adductor muscles, the arteriole length density (Ld) 18 and the number of arterioles/mm 2 tissue section 19 were calculated. Further details about histology procedures and quantifications performed in histological sections are provided in the Supplementary material online.
Real-time PCR analysis
To evaluate the presence of human DNA in adductor muscles injected with control (C) or SPIO-labelled (Fe) EPCs, DNA was extracted from non-ischaemic, C-and Fe-EPC-injected adductor muscles and processed for human polymorphism detection by real-time PCR as described in the Supplementary material online.
Statistical analysis
For in vitro MRI studies and in vivo DTI, statistical analysis was performed using linear correlation analysis for dose-response experiments. Two-way ANOVA with Bonferroni's post hoc analysis to analyse time-dependent and treatment-dependent observations; one-way ANOVA using Newman-Keuls post hoc analysis and Student's t-test, respectively, were used to compare results at single experimental time points. These analyses were performed using GraphPad statistical software.
Results
Iron particle loading procedure and phenotype analysis of SPIO-labelled EPCs
In the present study, human early EPCs were used; these cells have been shown to have a mixed endothelial/monocyte/myeloid phenotype. 20 In initial experiments, we assessed the ability of these cells to be efficiently labelled with SPIO particles, established the minimal number of cells that produced significant decrease in T2 values, and assessed the phenotype of unlabelled EPCs (C-EPCs) and iron-stained EPCs (Fe-EPCs). Results described in the Supplementary material online, Figures S2 -S4 allowed to set a minimal reference number of iron-loaded cells to be used in the following in vivo MRI experiments, and showed that iron loading did not affect EPCs phenotype.
MRI and histochemical analysis of control and SPIO-loaded EPCs in a mouse model of hind limb ischaemia
We have previously shown that injection of human cord bloodderived CD34 þ cells increases angiogenesis in pharmacologically immunosuppressed CD1 strain mouse model of hind limb ischaemia. 16 Figure 1A shows the main actions and timing of the in vivo experimental programme that were performed in the present study using this model. EPCs were incubated for 2 days with SPIO particles and were injected into ischaemic adductor muscles in immunosuppressed mice at the time of femoral artery dissection. T2-weigthed images of ischaemic mice indicated the presence of oedema in the ischaemic adductor muscles both at 24 h and at 7 days after ischaemia (see Supplementary material online, Results and Figure S5 ). T2* imaging sequences in Fe-EPC-injected mice revealed the presence of lowered T2 areas (dark spots) in the ischaemic limbs at 24 h and 7 days after ischaemia ( Figure 1B) . These areas were never observed in non-ischaemic, contralateral (CL) limbs or in limbs injected with C-EPCs or saline. Interestingly, dark spots were similar in ischaemic limbs at short time after injection and at 7 days, suggesting the absence of iron-loaded cells migration in the ischaemic muscle. To assess a potential relationship between lowered T2 areas in MRI sequences and the presence of SPIO-loaded cells, histological investigation was performed. Figure 1B shows the presence of deep blue, Pearl's stained cells in sections from muscles injected with Fe-EPCs. As expected, these cells were only observed in Fe-EPCs and not in C-EPCs or saline-injected mice. Different MRI studies have described the persistence of hypo-intense signal areas into ischaemic hearts injected with ironloaded progenitors at several weeks after transplantation. 21, 22 To assess whether the dark spots observed at 7 days in our MRI sequences were due to survived human EPCs or to iron accumulation into host macrophages, we performed immunohistochemistry in histological sections, where iron þ cells were detected by Pearl's staining. We used two different approaches consisting in immunolocalization of mouse macrophages by using a mouse CD68 monoclonal antibody and detection of human cells using HLA-DR and HLA-ABC-specific antibodies. As shown in Figure 2 , the totality of cells stained with Pearl's were positive for mouse CD68; conversely, none of these cells expressed human HLA-ABC or HLA-DR antigens, suggesting that iron released by dead EPCs was taken up by host macrophages invading the ischaemic tissue.
To confirm the absence of living human cells at 7 days after injection into ischaemic adductor muscles, we set a qPCR method to detect the presence of a human polymorphism in DNA preparations from EPC-injected (C and Fe) and CL adductor muscles. This was done using a protocol that allows to detect low amounts of human DNA using primers that specifically amplify the rs6625561 C/T polymorphism present in the Xq13.1b human genome region (see Supplementary material online, Figure S6) . The results showed the presence of C-EPCs and Fe-EPCs in ischaemic adductor muscles at 1 and 3 days post-ischaemia and transplantation; at 7 days, no signal was detected until 50 amplification cycles, indicating the complete absence of living human cells (see Supplementary material online, Figure S7 ).
Angiogenic effect of control and SPIO-loaded EPCs
Angiogenic effect of early EPCs has been previously investigated in several pre-clinical studies. Given their mixed composition of monocyte-derived 23 -25 and immune-like cells, 26, 27 their action appears to be mostly paracrine. 28 To assess whether C-or Fe-EPCs stimulated blood vessel formation in our hind limb ischaemia model, we determined the arteriole Ld in saline-and EPC-injected (C-EPCs and Fe-EPCs) adductor muscles by immunohistochemistry for a-actin at 7 days after ischaemia. A significant arteriolar Ld increase was observed in both C-EPC-and Fe-EPC-injected limbs ( Figure 3) . Morphometric analysis allowed to further discriminate between small, intermediate, and large arterioles. 18, 29 By applying this classification to calculate the arteriole number/mm 2 in tissue sections, it was found that the density of smaller arterioles (those having an r min comprised between 4 and 11 mm and, likely, the first newly formed arterioles into ischaemic tissues) was significantly increased both in C-EPC-and A. Gianella et al.
Fe-EPC-injected muscles. In contrast, the density of large and intermediate size arterioles (11 mm , r min , 41 mm) was not significantly affected.
DTI reveals a link between EPC injection, enhanced inflammation, and retarded ischaemic muscle regeneration
We applied DTI to determine whether injection of human EPCs alters the normal pattern of muscle regeneration in the ischaemic limbs. In analogy with previous reports showing DTI application in skeletal muscle, 10 -12,30 we injected saline solution or EPCs in the gastrocnemius muscles of ischaemic limbs after removal of the femoral artery, and extended the analysis time up to 21 days to cover the skeletal muscle degeneration and regeneration periods. CL limbs in these mice were chosen as an internal reference for diffusion anisotropy indices calculation. Finally, in these experiments, iron-labelled EPCs were not used for the reason that the presence of dark spots would likely interfere with water diffusion indices derivation from MR-derived DTI pixel maps. Figure 4A describes the trends of T2, ADC, and FA, whereas Figure 4B shows the temporal changes in l 1 , l 2 , and l 3 tensor eigenvalues. As shown in the histograms in Figure 4A and B, all values remained fairly constant in CL non-ischaemic limbs (white bars). In contrast, major changes were observed in these parameters in ischaemic muscles as a consequence of ischaemia and saline (grey bars) or EPCs (black bars) injection.
T2 values, directly referable to the presence of unbound water due to tissue oedema, were significantly elevated in both treatments compared with CL muscles until 14 days. Interestingly, T2 returned to basal levels at 21 days in saline-injected mice. At this time point, this effect was not observed in mice receiving EPCs, suggesting a longer oedema permanence in EPCs-injected tissues. ADC, a parameter that can be generally related to the size of the diffusing compartment in the muscle, was, at early times (24 h and day 3), significantly higher than in CL muscles in salineand EPC-injected animals. This likely reflected the presence of swollen muscle fibres due to ischaemia. ADC values tended to decrease compared with CL limbs starting at day 14 both in saline-and EPC-injected muscles. Notably at 14 and 21 days, ADC values in saline-injected muscles were significantly higher compared with EPCs-injected muscles and more similar to values observed in CL muscles. Finally, FA, a parameter that can be referred to the influence of the fibres form (length/section) on the ability of water to diffuse intramuscularly, was never different between EPC-injected muscles and CL muscles; conversely, it became significantly higher in saline-injected mice, likely reflecting a more complete fibre regeneration process compared with EPC-injected mice.
Different trends were also noticed in l 1 , l 2 , and l 3 tensor eigenvalues ( Figure 4B) showing high values at early times (24 h and day 3) that became progressively lower at late times (days 14 and 21) after ischaemia. Differences were noticed by statistically comparing the eigenvalues measured in EPC-and saline-injected muscles to values observed in CL muscles. In fact, in EPC-injected muscles, they were, in most of the cases, significantly lower compared with CL muscles. In contrast, these differences were never observed between CL vs. saline-injected muscles. Interestingly, two-way ANOVA data analysis revealed also a highly significant difference (P , 0.001) in the time factor dependency of the three eigenvector values in the presence or in the absence of injected EPCs over the time of experiment, again suggesting overall different trends in muscle healing process in the presence or in the absence of human cells. Altogether, these data indicated lower dimensions of regenerating muscle fibres in EPC-injected compared with saline-injected muscles at late time points suggesting a retarded regeneration process.
The advantage offered by DTI analysis is that it allows to correlate eigenvalues and diffusion indices (T2, ADC, and FA), derivable 
Fe-EPC-injected ischaemic adductor muscles (arrows). (B, D, and F)
The mouse CD68, human HLA-ABC, and HLA-DR antigens immunostaining in the same section as in (A, C, and E), respectively. As evident in (B), cells that were iron þ in (A) were stained by anti-CD68 mouse-specific antibody, whereas none of the iron þ cells shown in (C and E) were stained for human major histocompatibility complex.
In vivo MRI of human EPCs from signal integration of MR-based pixel maps, to structural features of skeletal and cardiac muscles. 9 -11,30 Therefore, to establish a link between the structure of saline-and EPC-injected muscles and the differences observed in the water diffusion indices in the two treatment conditions, we performed a histological investigation on cross-sections of saline-and EPC-injected gastrocnemius muscles at 21 days. As shown in Figure 5A -D, the morphology of these muscles was dramatically different. In fact, in EPC-injected mice, an increased density of young fibres carrying centrally located nuclei, a lower fibre size, and more abundant blood vessels (see Supplementary material online, Figure S8 ) were observed. To quantify these differences, we determined three parameters describing the geometry of regenerating muscle fibres in these muscles, using a computer-assisted method. These were the average areas of regenerating fibres ( Figure 5E ), their average perimeter ( Figure 5F ), and their average major axis measure ( Figure 5G ). These three measures were all different with high significance levels (P , 0.0001) in EPC-injected compared with saline-injected muscles, revealing a dramatic change in the structural organization of muscles receiving cells at 21 days following ischaemia. Finally, histological analysis revealed also that several foci of macrophages infiltration were still present at 21 days in EPC-injected muscles, whereas they were only occasionally observed in saline-injected mice (see Supplementary material online, Figure S8 ). This suggests that the presence of inflammation at these late time points retarded the physiological muscle regeneration process.
Discussion
In animal models, different methods are available to evaluate stem cell engraftment either post post-mortem (immunohistochemistry, donor chromosome identification, quantification of donor-derived DNA in myocardial tissue) or in living conditions (i.e. Firefly luciferase detection, enhanced green fluorescent protein cells analysis/ sorting). 1 In contrast, in patients, the effect of stem cells administration can be only indirectly inferred by the evaluation of heart functional parameters (i.e. ejection fraction, end-systolic volume, scar size, etc.) and/or high-resolution investigations of myocardium structure, metabolism, and vitality by, that is, computed tomography (CT), MRI, SPECT or PET. 7 The development of novel hybrid cameras, such as SPECT/CT and PET/CT, allows for multiple recordings of heart morpho-functional data at the same time. However, the application of these advanced techniques to follow stem cells in patients has a major limitation in the reliability of stem cell labelling using procedures that can be translated into clinical practice (discussed in refs 7, 31 ), and the need for minimizing the risk for false-positive detection. A. Gianella et al.
MRI of SPIO-loaded EPCs is not reliable to assess life span of injected progenitors into ischaemic tissues
MRI has been used in pre-clinical models of myocardial infarction to follow the fate of SPIO-loaded embryonic stem cells 21, 32, 33 and MSCs 22, 34 at longer times compared to isotope-labelled cells. 35 The main finding from these studies was the persistence of dark spots in T2-weighted images of injected myocardium until 4 weeks after injection, suggesting survival of transplanted cells. Despite the relatively high number of reports showing persistence of these dark spots, only few investigations have focused on detailed phenotype analysis of iron-stained cells at late stages after injection. For example, two recent investigations have called for caution about the use of SPIO loading for effective detection of injected MSCs and cardiac-derived stem cells in the heart using MRI. In fact, both reports showed persistence of 'signal void' areas at the sites of stem cell injection that was mostly, if not entirely, due to uptake of iron particles released from dead cells by host macrophages. 14, 15 In line with these results, using immunohistochemical methods, we In vivo MRI of human EPCs found that EPCs did not survive in the ischaemic limbs and that ironloaded cells were CD68 þ resident macrophages that did not express human HLA antigens. Moreover, we did not find the presence of human DNA beyond 3 days after injection. Therefore, we conclude that at least under our conditions, the life span of injected EPCs was short and that the leakage of iron particles by dead progenitors and their capture by macrophages might be a major hurdle to the use of MRI to reliably identify EPCs homing and behaviour into ischaemic tissues.
Early death of injected EPCs does not preclude an effect on neovascularization into ischaemic tissue
The aim of our study was to determine the outcome of human early EPC injection in the context of peripheral acute ischaemia and to correlate this outcome to survival of injected cells and imaging of injected tissues by MRI. We found that progenitor cell injection increased arteriogenesis in the ischaemic limb. This was, however, in striking contrast with the mouse macrophage phenotype of the iron-stained cells and the absence of human DNA at 7 days after ischaemia.
How to reconcile this apparent contradiction? A possible explanation may come from studies describing the phenotypic and biological features of early and late EPCs. 13 The main differences between the two EPC types consist in a lineage separation based on the expression of the pan-haematopoietic marker CD45 (expressed in early, but not in late, EPCs), the in vitro clonogenicity (low or null in early, and very high in late EPCs 36 -38 ), and the different role of the two cell types in neovascularization induction (a paracrine mechanism for early and direct incorporation into forming vessels for late EPCs 20 ). The composite nature of early EPC colonies, consisting of monocyte-derived cells and 'angiogenic' T-and B-cells, 23, 26, 27, 35, 39 results in the secretion of a variety of pro-angiogenic and pro-inflammatory cytokines. For example, it has been shown that vascular endothelial growth factor and interleukin-8 secreted by early EPCs 28, 40 have an effect on vascular regeneration priming by activating extracellular matrix remodelling by metalloproteases (MMP) secretion, 28 pro-inflammatory mediators, 41 and/or by stimulating recruitment of bone marrow-derived circulating progenitors. 40 Additionally, it has been found that injection of human early EPCs induces expression of multiple humoral factors that protect ischaemic myocardium from death and sustain vascular regeneration, independently on progenitor cells survival. 42 
Figure 4 Continued
Our results are consistent with these studies; in fact, we found that C-and Fe-EPCs had a composite phenotype consisting of hematopoietic-derived cells (as witnessed by high CD45 and CD48 expression levels) and of mixed endothelial/immune-like cells (as revealed by expression, although at lower levels, of CD105, CD31, and CD3). In line with the so-called 'dying stem cell hypothesis', 43 our findings thus suggest an in situ release of pro-inflammatory and pro-angiogenic cytokines by C-and Fe-EPCs at early times after injection, which was likely sufficient induce neovascularization into the ischaemic muscle independently of progenitor cells survival.
4.3 Enhanced vascular and retarded muscle regeneration into the ischaemic environment-opposite EPC effects through a unique player: the inflammatory response
To monitor muscle regeneration after injection of human EPCs, we used DTI, an MR-based protocol that has been used with success to derive structural information on skeletal muscle healing 11, 12, 30 and cardiac muscle scarring 9 after ischaemic injury. This technique
has not been applied yet to monitor the outcomes of progenitor Figure 5 Histological appearance of gastrocnemius muscles in saline-and EPC-injected mice. (A) A haematoxylin -eosin staining of a gastrocnemius muscle cross-section in a saline-injected muscle at 21 days post-ischaemia. The presence of areas containing terminally differentiating muscle fibres characterized by the presence of centrally located nuclei (red arrows) and terminally differentiated fibres (red arrowheads) is evident. The area represented in red dashed box is magnified in (B), where a magnification of regenerating muscle fibres is shown. (C) The appearance of ischaemic gastrocnemius muscles injected with EPCs. In these muscles, the density of regenerating fibres appeared higher compared with saline-injected muscle. Magnification of the red dashed box in (D) shows the lower transversal dimensions of these fibres. (E -G) The quantification of the mean area (E), the mean perimeter (F), and the major axis length (G) of regenerating muscle fibres in four selected areas in ischaemic gastrocnemius muscles sections from three mice injected with EPCs and saline. *P , 0.0001 statistical difference calculated by Student's t-test (6308 and 9226 fibres counted from three mice injected with saline and EPCs, respectively).
In vivo MRI of human EPCs cell injection into ischaemic disease models. This is surprising, given the potential translational interest of this procedure to obtain 3D reconstruction of skeletal and cardiac muscles following cellular therapy, using a widely accessible and non-invasive technology such as MR. Ischaemic, toxic, or exercise damage in the skeletal muscle is accompanied by regeneration of the muscle fibres. This occurs through a tightly orchestrated process involving several genes and cell types (reviewed in Gayraud-Morel et al.
44
). The inflammatory response, and macrophages as a major cellular component in the inflammation associated with innate immunity, plays a key role in skeletal muscle healing after injury (reviewed in refs 45, 46 ). This is a two-stage event involving an initial pro-inflammatory activity of infiltrated monocytes, followed by a later conversion into an antiinflammatory macrophage phenotype sustaining myogenesis and muscle fibre terminal differentiation. 47 Our MR-based DTI mapping supports the hypothesis that EPC injection caused a modified response in the ischaemic tissues that likely extended the pro-inflammatory period and caused, paradoxically, a retarded muscle regeneration. This hypothesis is based on the persistence of oedema (T2 maps), the lower water diffusivity (ADC data), and the lower effect of fibres form on water diffusion (FA data) in EPC-injected compared with saline-injected muscles. Histological data and diffusion tensor eigenvalues measures further support this view. In fact, we found that three geometric parameters of the regenerating muscle fibres (average area, perimeter, and major axis) and the three main direction and forces associated with water diffusion tensor (l 1 , l 2 , and l 3 ) were, at late times (14 and 21 days), significantly lower compared to CL muscles when ischaemic limbs received EPCs. Finally, the presence of macrophages associated with muscle fibres was recurrently observed until 21 days in EPC-injected muscles. These major differences were not observed or were quantitatively less pronounced in ischaemic limbs receiving saline solution, thus indicating that in the absence of cells, muscle regeneration process was almost completed within the 21 days period. Remarkably, in a previous report from our laboratory, it was shown that administration of human cord blood-derived, CD34
þ -selected progenitors into ischaemic limbs enhanced angiogenesis and, opposite to our present findings, contributed to muscle regeneration without enhancing the inflammatory response. 16 In that study, the hind limb ischaemia model was identical to that used here, performed using immunocompetent mice that were pharmacologically immunosuppressed. Cyclosporin A is a drug that is known to abolish the T-and B-cell-mediated immune reaction but to only minimally affect the activity of tissue macrophages. 48 A possibility to explain this discrepancy is that early
EPCs have a different inflammation regulatory activity compared with selected CD34 þ cells.
Concluding remarks
It is beyond the scope of the present study to assess whether EPC injection alters the physiological shift of host macrophage function from the pro-to the anti-inflammatory phenotype, thus turning a physiological into a pathological muscle healing process. However, the priming of a persisting inflammation, similar to that observed in genetic disorders associated with chronic muscle wasting (discussed in refs 45, 46, 49 ) , may be a possible explanation for a simultaneous induction by EPCs of enhanced angiogenesis and impaired muscle regeneration in the ischaemic microenvironment. By revealing the complex interplay between injected progenitors and cells acting in the physiological response to ischaemic injury, future studies will be necessary for an understanding of these 'Janus-like' effects 50, 51 and to apply suitable protocols to enhance positive outcomes (enhanced neovascularization) and limit negative effects (enhanced scar formation) of cellular therapy in peripheral ischaemic disease.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
